Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating donor stem cell transplantation for patients with relapsed hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Neoplasm

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED